These findings align with previous genomic studies of cervical adenocarcinoma, which highlight PIK3CA, TP53, and KRAS as key drivers, frequently implicated in the PI3K/AKT, MAPK, and cell cycle regulatory pathways [37,38,39,40]. This evidence concerns the gene PIK3CA and cervical adenocarcinoma.